MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 69 filers reported holding MEI PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $31 | -63.1% | 134,760 | -60.7% | 0.00% | – |
| Q4 2022 | $84 | -100.0% | 343,286 | -52.7% | 0.00% | – |
| Q3 2022 | $280,000 | -66.2% | 725,106 | -47.1% | 0.00% | -100.0% |
| Q2 2022 | $829,000 | +208.2% | 1,370,656 | +1258.4% | 0.00% | – |
| Q4 2021 | $269,000 | -79.7% | 100,900 | -79.0% | 0.00% | -100.0% |
| Q3 2021 | $1,325,000 | -23.2% | 480,024 | -20.7% | 0.00% | 0.0% |
| Q2 2021 | $1,725,000 | +24.9% | 605,211 | +50.3% | 0.00% | 0.0% |
| Q1 2021 | $1,381,000 | -20.9% | 402,690 | -39.1% | 0.00% | 0.0% |
| Q4 2020 | $1,746,000 | -44.5% | 661,512 | -34.4% | 0.00% | -75.0% |
| Q3 2020 | $3,144,000 | -34.6% | 1,007,768 | -13.5% | 0.00% | -42.9% |
| Q2 2020 | $4,810,000 | +430.3% | 1,164,738 | +106.8% | 0.01% | +250.0% |
| Q1 2020 | $907,000 | -47.0% | 563,310 | -18.3% | 0.00% | 0.0% |
| Q4 2019 | $1,710,000 | -30.2% | 689,349 | -52.7% | 0.00% | -50.0% |
| Q3 2019 | $2,449,000 | -38.4% | 1,457,785 | -8.3% | 0.00% | -33.3% |
| Q2 2019 | $3,975,000 | +86.8% | 1,590,091 | +129.4% | 0.01% | +100.0% |
| Q1 2019 | $2,128,000 | +300.0% | 693,133 | +243.8% | 0.00% | +200.0% |
| Q4 2018 | $532,000 | -92.2% | 201,585 | -87.2% | 0.00% | -87.5% |
| Q3 2018 | $6,787,000 | +23.5% | 1,574,678 | +12.9% | 0.01% | +14.3% |
| Q2 2018 | $5,495,000 | +24877.3% | 1,394,790 | +13117.0% | 0.01% | – |
| Q1 2018 | $22,000 | -83.9% | 10,553 | -79.4% | 0.00% | – |
| Q3 2017 | $137,000 | -33.2% | 51,272 | -40.3% | 0.00% | – |
| Q2 2017 | $205,000 | +485.7% | 85,833 | +333.7% | 0.00% | – |
| Q3 2016 | $35,000 | -94.8% | 19,793 | -94.7% | 0.00% | -100.0% |
| Q1 2015 | $668,000 | -76.8% | 372,643 | -44.7% | 0.00% | -66.7% |
| Q4 2014 | $2,880,000 | +2150.0% | 674,407 | +3539.5% | 0.01% | – |
| Q3 2014 | $128,000 | -95.7% | 18,530 | -93.1% | 0.00% | -100.0% |
| Q1 2014 | $2,995,000 | -0.2% | 269,131 | -28.1% | 0.01% | 0.0% |
| Q4 2013 | $3,000,000 | -11.3% | 374,506 | +24.6% | 0.01% | -18.2% |
| Q3 2013 | $3,382,000 | +41.4% | 300,662 | -10.4% | 0.01% | +57.1% |
| Q2 2013 | $2,392,000 | – | 335,553 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |